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CNBr treatment of rod outer segments was performed in dark and in light conditions. With the subsequent 
modified rhodopsin and opsin the cGMP phosphodiesterase activation system was reconstituted. The re- 
combination systems exhibited greatly reduced G-protein binding, GTPyS binding and cGMP phosphodi- 
esterase activation. The reduction in activity of these three steps of the PDE activation cascade is most sig- 
nificant with modified opsin and is shown to be due to its inability to bind the Ga subunit. The correlation 
between the localization of CNBr cleavage in dark and light conditions and these results is strongly indica- 
tive that a light-induced conformational change occurs in two extradiscal regions of rhodopsin. 
Rhodopsin G-protein G TP binding cGMP phosphodiesterase CNBr digestion Conformational change 
1. INTRODUCTION 
Three components have been demonstrated to 
be involved in the cGMP enzymatic cascade of 
visual transduction in vertebrate photoreceptor 
cells. These are the light receptor rhodopsin, G- 
protein (GTP binding protein, transducin) and 
cGMP phosphodiesterase (PDE). Upon illumina- 
tion, rhodopsin undergoes a conformational 
change leading to an active state (R*) shown to be 
essentially the photoproduct metarhodopsin II 
[1,2]. R* interacts with the peripheral membrane 
protein, G-protein, which then exchanges a bound 
GDP for GTP, inducing dissociation of the R/G- 
protein complex after a period of milliseconds [3]. 
The G-protein-GTP complex activates PDE 
(which hydrolyzes cGMP to 5 ’ -GMP) by displace- 
ment of an inhibitory constraint [4]. In the accom- 
panying paper [6] we describe a procedure of 
Abbreviations: G-protein, GTP binding protein or 
transducin; PDE, phosphodiesterase; ROS, rod outer 
segments; GTP$3, non-hydrolyzable GTP “S y-labeled; 
ROS, rod outer segments 
CNBr treatments of ROS to investigate the light- 
induced conformational change in the extradiscal 
regions of rhodopsin. Here, we have studied the 
impact of the CNBr modifications of rhodopsin 
(and opsin) on three different stages of the PDE 
cascade. 
These are its ability to: (i) bind G-protein; (ii) 
catalyze G-protein GTPyS binding; and (iii) pro- 
voke the activation of PDE. At each of these three 
stages of the PDE-activation cascade we have 
observed a difference between unbleached ROS 
treated with CNBr and ROS treated after 
illumination. 
2. MATERIALS AND METHODS 
All procedures were performed at 0 or 4°C 
under dim red light unless otherwise stated. 
Bovine ROS were purified according to a stan- 
dard procedure [5] and were divided into two por- 
tions as shown in fig.1. One portion was kept in 
darkness, the other one illuminated for 1 min at 
0°C under white light. ROS samples were treated 
with CNBr and the resulting modified rhodopsin 
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Fig.1. Experimental scheme for monitoring the light- 
induced conformational change of rhodopsin. The two 
species of rhodopsin (Rh, Rh-B) and those of opsin 
(Ops, Ops-B) were prepared as described in the 
preceding communication. The final step called G- 
protein binding includes the GTP binding to the G- 
The phosphodiesterase activation was estimated 
by comparing the effect of the different rhodop- 
sins and opsins on the basal PDE activity. Rh and 
Rh-B suspensions were illuminated for 1 min at 
0°C producing 75% bleaching. Bleached rhodop- 
sins and opsins were recombined with DTE in the 
same conditions as in [9] and the [3H]cGMP 
hydrolysis was measured according to Thompson 
and Appleman [lo]. 
protein. 3. RESULTS 
(Rh-B) and opsin (Ops-B) were purified as de- 
scribed in the accompanying paper [6]. 
Soluble ROS proteins were prepared from 
freshly purified ROS by immediate extraction with 
10 mM (pH 7.5) Tris-HCl buffer containing 
1 mM EDTA and 1 mM dithioerythritol. This ex- 
tract termed DTE (Dark Tris Extract) containing 
the G-protein, PDE and its inhibitor were stored in 
liquid nitrogen until use. 
For G-protein binding experiments modified 
rhodopsins were recombined with soluble ROS 
proteins from DTE, each mixture contained 
0.4 mg purified rhodopsin and the DTE from ROS 
corresponding to 2 mg rhodopsin in a (pH 8.0) 
100 mM Tris-HCl, 2 mM Mg2+ buffer. Each 
recombined suspension was illuminated according 
to [7] then immediately centrifuged for 30 min at 
100000 x g. The pellet was extracted first with 
1 ml of the hypotonic Tris buffer used above for 
extracting soluble ROS proteins (termed LTE), 
and then with the same buffer containing 2 mM 
Mg2+ and 100 PM GTP (termed GTP E). The first 
and the second extracts were submitted to elec- 
trophoretic analysis together with the original 
DTE. 
Rhodopsin- or opsin-catalyzed GTPyS binding 
in DTE was estimated using a nitrocellulose filtra- 
tion method adapted from that described by Nor- 
thup et al. [8]. To a preincubated (3 min, 30°C) 
tube containing 50111 of 40 mM Tris-HCl (pH 
8.0), 2 mM MgC12, 5 FM GTPyS (250000 cpm) 
and rhodopsin or rhodopsin derivative (as de- 
scribed in the legend to fig.3) were added 50~1 
DTE. After incubation (5 min, 30°C) the sample 
was applied to a damp nitrocellulose filter under 
suction then washed and counted for radioactivity 
according to [8]. 
Fig.2 shows polyacrylamide gels of soluble ROS 
protein extracts after recombination of modified 
DIE. LXE. GTP-E. 
+ 
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Fig.2. SDS-polyacrylamide gel electrophoresis of soluble 
extracts from the binding experiment. DTE, hypotonic 
dark Tris extract obtained directly from dark-kept ROS. 
DTE was associated as described in fig.1. LTE, 10 mM 
light Tris extract corresponding to the first extract after 
the recombination. GTP-E, GTP extract corresponding 
to the third set of supernatants. Rh, rhodopsin; Ops, 
opsin; Rh-B, CNBr-treated rhodopsin; Ops-B, CNBr- 
treated opsin. 
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or not r~~~~~i~ and opsin with DTE. The DTE 
profile is shown in the first trace and contains, in 
addition to PDE, the three subunits of the G- 
protein [ 11,121. After recombination of rhodopsin 
species with DTE on the bulk of rhodopsin un- 
bound proteins were recovered in the 10 nM LTE. 
As expected, both illuminated Rh and Ops prevent 
the extraction of the G-protein and chiefly of the 
cu-subunit in the light Tris extracts (LTE Rh and 
LTE Ops traces of fig.2). The G-protein complex 
becomes extractable only in the presence of GTP 
and magnesium (GTP Rh and GTP Gps traces)_ 
On the contrary, in the recombination assays of 
DTE with CNBr modified rhodopsin and opsin, 
the G-protein extractability is no longer prevented 
by light (LTE Rh-B and LTE Gps-B traces). Note 
that the GLu-subunit is predominant in the extract 
corresponding to Ops-B. Respective GTP extracts 
confirm that a weak binding of the G-protein oc- 
curs on bleached Rh-B and no binding on Ops-B 
(GTP-E Rh-B and GTP-E Ops-B traces). 
The binding of a non-hydrolyzable GTP 
analogue (GTPrS) to the G-protein of the DTE ex- 
tract was studied in the presence of three species of 
rhodopsin: rhodopsin control (Rh), CNBr-treated 
rhodopsin (Rh-B) and CNBr-treated opsin (Ops-B) 
(fig.3). 
The ability of DTE to bind GTPyS is greatly 
enhanced by the addition of 0.5 /Ig photoactivated 
rhodopsin, CNBr treatment (Rh-B) greatly 
diminishes the ability of rhodopsin to catalyze this 
binding (0.5 pg). Addition of excess of Rh-B (i.e., 
5 pg) partially enhances GTPyS-binding sug- 
gesting that, in this derivative, this function is par- 
tially conserved. fn the case of Ups-B, both at 
0.5 pg and 5.0 ~g, the ability to catalyzeGTPyS 
binding is completely abolished. 
The effect of CNBr treatments of ROS is 
reflected on the light activation of PDE as shown 
in fig.4. The light activation of PDE is bleached 
rhodopsin concentration-dependent and the basal 
PDE activity (in darkness) can be enhanced up to 
5-6 times by bleached rhodopsin as well as by op- 
sin. However, the abihty of bleached rhodopsin to 
trigger PDE activation is clearly altered by CNBr 
modification. Moreover, there is a dramatic dif- 
ference between the effects obtained with Rh-B 
and Ops-B: in the case of Rh-B the capacity of 
bleached rhodopsin to activate PDE is only partial- 
ly lost @O-70% of the activation of the rhodopsin 
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Fig.3. The effect of CNBr treatment on the abiiity of 
rhodopsin to cataIyze DTE GTPTS-binding. Experi- 
ments were performed indifferent& under Iight or dark 
conditions. Rhadopsin and CNBr-treated rhodopsin and 
opsin being exposed to white light (5 min, greater than 
90% bleaching) before use. Bars: (no symbofs) Contrcll 
without rhodopsin; (I) Rh; (a) Rh-B; (.) Qps-B. 
QPS-6 
I L 
0.5 1.0 1.5 2.0 
bleached rhodopsin (jig 1 
Fig.4 The effect of CNBr treatment on tbetability of 
bleached rhodopsin to activate the cGMP phospho- 
diesterase. Each DTE was from 0.2 retina, the maximum 
concentration of bleached rhodopsin species from 0.002 
retina (ratio 100). 
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control) whereas in the case of Ops-B it is com- 
pletely lost. To avoid the effect of eventual CNBr 
traces on PDE activity two controls were per- 
formed: (i) in some assays containing control 
rhodopsin or opsin CNBr was incorporated; no 
change was observed in the rhodopsin-dependent 
PDE activation; (ii) Rh-B and Ops-B were partially 
evaporated under vacuum to eliminate CNBr 
traces and the same values of PDE activity were 
obtained. 
4. DISCUSSION 
For monitoring light-induced conformational 
changes of rhodopsin, we used reconstitution 
assays with membrane vesicles containing purified 
visual pigment. Thus we can attest that all the ef- 
fects observed on the cGMP PDE cascade are due 
to modified rhodopsin. 
In the first investigated stage of the cGMP 
cascade the light-induced binding of G-protein was 
affected both with Rh-B and Ops-B indicating that 
rhodopsin extradiscal regions were modified by 
CNBr treatment. If we compare the G-protein 
binding (and chiefly the Gcu-subunit) between the 
two species of rhodopsin and those of opsin, it is 
obvious that the binding site of G-protein is most 
affected in Ops-B where it seems to be severely 
damaged. A reduced binding has been already 
observed after thermolysin treatment of ROS but 
the so digested rhodopsin still partially retained its 
capacity to bind the G-protein [7]. 
Efficient GTP-GDP exchange occurs on G- 
protein only if the Ga-subunit in the presence of 
Gfi and Gy interacts with photolyzed rhodopsin 
[13]. This interaction being greatly reduced with 
Rh-B and prevented with Ops-B, we expected and 
observed a reduced binding of GTPyS on G- 
protein with Rh-B and Ops-B. At this second stage 
of cGMP cascade once again the inhibition effect 
is more pronounced with Ops-B. 
We verified that these differences are still 
reflected at the final stage of the cascade, i.e., PDE 
catalytic activity. Recombination of DTE with 
Ops-B yielded much lower levels of activated PDE 
than Rh-B. When rhodopsin is modified with 
5-times more CNBr the activation of PDE by Rh-B 
is diminished by 50% but is never suppressed as is 
the case with Ops-B. Incubation of ROS with 
CNBr was also performed for time lengths as long 
as overnight (12 h): not only the yield of cleavage 
is not significantly increased but the structure of 
the rhodopsin control is destabilized as attested by 
its absorption spectrum and the loss of its capacity 
to activate PDE. On the other hand, the binding 
site of G-protein is only partially accessible to ex- 
tradiscal reagents in darkness and becomes ex- 
posed upon illumination of rhodopsin. 
In the preceding communication we showed that 
CNBr treatments of disc membranes resulted in 
modification and cleavage of the C-terminal 
region, as well as the third and the second ex- 
tradiscal loops of rhodopsin. We observed an in- 
crease in the yield and a qualitative difference in 
the cleavage when the disc membranes were 
bleached prior to the CNBr treatment. These 
cleavage differences are due only to the conforma- 
tional changes occurring after illumination of 
rhodopsin. This difference has been monitored 
here by modifications at three levels of the cGMP 
cascade. Illumination of rhodopsin causes a higher 
susceptibility of the C-terminal end to CNBr 
cleavage 161 or to thermolysin digestion 1141 but 
this region does not participate directly to the bind- 
ing site of G-protein [7,15]. After a complete 
cleavage of the third extradiscal loop (without 
modifying the second one) obtained by limited 
thermolysin proteolysis [7] the binding of G- 
protein is not completely suppressed. Although 
several bonds of rhodopsin are cleaved by CNBr 
we can deduce from the proceeding observations 
and the differences between Rh-B and Ops-B that 
both the third and the second extradiscal loops are 
involved in the interaction with the G-protein, 
The isomerization by light of 1 l-c&retinal pro- 
duces a conformational change of the regions in- 
volved in the retinal pocket leading presumably to 
a vertical shift of helices 4 and 6, connected to the 
second and third extradiscal loops, respectively, 
towards the extradiscal space. These light-induced 
conformational changes should be the key of the 
reversible formation of the G-protein binding site. 
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